2023年5月，加拿大AI生物医药文献搜索平台BenchSci宣布完成9500万美元D轮融资。本轮融资由Generation Investment Management、F-Prime Capital、Golden Ventures、TCV以及iNovia Capital等参透。据悉，本轮融资金额将被用于拓展BenchSci的开创性的人工智能（AI）药物研发平台ASCEND?，该 ...

TORONTO--(BUSINESS WIRE)--BenchSci, a world leader in AI solutions for preclinical life sciences research and development (R&D), today announced a $95 million (US $70 million) Series D funding round ...

TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- BenchSci, a world leader in AI solutions for drug discovery, today announced the launch of its latest technology, ASCEND™ by BenchSci, helping remove ...

「BenchSci」于5月25日宣布，其已获得9500万美元的D轮融资，投资者包括Generation Investment Management、F-Prime Capital、Golden Ventures、TCV以及iNovia Capital。据悉，本轮融资将用于拓展该公司开创性的人工智能（AI）药物研发平台ASCEND™，该平台使科学家能够发现生物信号间的 ...

BenchSci became one of Canada’s most promising and heavily funded startups by using artificial intelligence to help pharmaceutical giants cut time and costs from the drug discovery process. Now the ...

搜索速度能够提高24倍，挑选抗体的成本减少75%。 新药从研发到上市往往伴随着复杂的流程和高昂的成本。在美国，一款新药想要成功上市，往往需要经过将近10年的时间，花费数十亿美元的研发和推广费用。研发过程中，无论是实验原料的搜集，还是实验中 ...

BenchSci aims to help pharma companies speed up R&D using AI. Toronto-based BenchSci, which helps pharmaceutical firms accelerate research and development (R&D) using artificial intelligence (AI), has ...

BenchSci confirmed to BetaKit that it laid off 17 percent of its workforce. Toronto-based artificial intelligence (AI) and biomedical startup BenchSci has reduced its headcount as the startup looks to ...

Toronto, Aug. 06, 2021 (GLOBE NEWSWIRE) -- BenchSci, an emerging global leader in machine learning applications for novel medicine development, announced today that Principal Engineer Craig Newell has ...

Toronto startup BenchSci Analytics Inc., which uses artificial intelligence to help biomedical scientists cut time and costs from research, is extending its reach with a US$22-million fundraising ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Assessing the health of pharmaceutical R&D ...